BlackRock Health Sciences Trust (BME) shareholders
BMENYSE
$48.05+0.21 (+0.44%)
Close on Nov 11, 2026Market cap –P/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3M
Shares held, 13F filers
Institutional holders
79
11 new, 8 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BME | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 364,745 | – | $15.67M | +6,827 | 0.00% |
| Bank Of America Corp /De/ | 275,369 | – | $11.83M | +8,870 | 0.00% |
| 1607 Capital Partners, LLC | 163,553 | – | $7.02M | −69,707 | 0.61% |
| Wells Fargo & Company/Mn | 159,824 | – | $6.86M | +6,897 | 0.00% |
| Royal Bank of Canada | 154,876 | – | $6.65M | −5,806 | 0.00% |
| Nova R Wealth, Inc. | 140,936 | – | $6.05M | −13,681 | 1.77% |
| Karpus Management, Inc. | 140,338 | – | $6.03M | −1,104 | 0.17% |
| Invesco Ltd. | 130,083 | – | $5.59M | −4,569 | 0.00% |
| LPL Financial LLC | 113,128 | – | $4.86M | +5,367 | 0.00% |
| Raymond James Financial Inc | 109,811 | – | $4.72M | +2,375 | 0.00% |
| UBS Group AG | 96,906 | – | $4.16M | −12,115 | 0.00% |
| Ameriprise Financial Inc | 70,671 | – | $3.04M | +1,687 | 0.00% |
| Cornerstone Advisory, LLC | 54,477 | – | $2.34M | +603 | 0.19% |
| Cypress Capital Management LLC (WY) | 53,307 | – | $2.29M | +8,447 | 1.91% |
| Summit Financial, LLC | 51,920 | – | $2.23M | +3,878 | 0.02% |
| Wealthspire Retirement, LLC | 51,434 | – | $2.21M | −453 | 0.12% |
| Cambridge Investment Research Advisors, Inc. | 41,258 | – | $1.77M | +21,489 | 0.00% |
| First Trust Advisors LP | 29,063 | – | $1.25M | +2,556 | 0.00% |
| Commonwealth Equity Services, LLC | 28,981 | – | $1.24M | −2,013 | 0.00% |
| Kestra Advisory Services, LLC | 28,940 | – | $1.24M | +1,259 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | 3M | 11 / 26 | 22 / 8 | 0M | 0M |
| Q1 2026 | 76 | 3M | 12 / 25 | 24 / 10 | 0M | 0M |
| Q4 2025 | 77 | 3M | 12 / 24 | 23 / 10 | 0M | 0M |
| Q3 2025 | 76 | 3M | 14 / 22 | 27 / 9 | 0M | 1M |
| Q2 2025 | 72 | 3M | 16 / 23 | 21 / 11 | 1M | 0M |
| Q1 2025 | 67 | 3M | 8 / 24 | 24 / 13 | 0M | 0M |
| Q4 2024 | 73 | 3M | 16 / 18 | 25 / 12 | 0M | 0M |
| Q3 2024 | 73 | 3M | 6 / 20 | 33 / 2 | 0M | 0M |
| Q2 2024 | 69 | 3M | 6 / 21 | 27 / 10 | 0M | 1M |
| Q1 2024 | 73 | 4M | 12 / 24 | 21 / 11 | 1M | 0M |
| Q4 2023 | 73 | 3M | 12 / 22 | 23 / 11 | 1M | 0M |
| Q3 2023 | 72 | 3M | 8 / 26 | 22 / 5 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
3 funds held BME in Q2 2026, 100% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BME | Value | % of fund | As of |
|---|---|---|---|---|---|
| Invesco CEF Income Composite ETF | 118,899 | – | $4.78M | 0.58% | May 31, 2026 |
| First Trust Income Opportunities ETF | 25,004 | – | $1.01M | 1.27% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Charles Park | Chief Compliance Officer | – | Aug 5, 2026 |
| Stephen Thomas Minar | Vice President | – | May 16, 2025 |
| Francis C. Mahoney | Director | – | Sep 17, 2026 |
| H. Erin Xie | – | 11,450 | Feb 3, 2026 |
| Xiang Liu | – | 389 | Feb 3, 2026 |
| Kyle McClements | – | 1,234 | Feb 4, 2025 |
| Christopher Accettella | – | 821 | Feb 4, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Xiang Liu – | Jan 30, 2026 | Option exercise | +389.1 | – | – | 389 |
| Xiang Liu – | Jan 30, 2026 | Returned to company | −389.1 | $41.87 | $16.29K | 0 |
| H. Erin Xie – | Jan 30, 2026 | Option exercise | +11,449.51 | – | – | 11,450 |
| H. Erin Xie – | Jan 30, 2026 | Returned to company | −11,449.51 | $41.87 | $479.39K | 0 |
| H. Erin Xie – | Jan 31, 2025 | Option exercise | +13,471.13 | – | – | 13,471 |
| H. Erin Xie – | Jan 31, 2025 | Returned to company | −13,471.13 | $40.92 | $551.24K | 0 |
| Christopher Accettella – | Jan 31, 2025 | Returned to company | −202.02 | $40.92 | $8.27K | 821 |
| Christopher Accettella – | Jan 31, 2025 | Option exercise | +202.02 | – | – | 1,023 |
| Kyle McClements – | Jan 31, 2025 | Option exercise | +641.44 | – | – | 1,234 |
| Kyle McClements – | Jan 31, 2025 | Returned to company | −641.44 | $40.92 | $26.25K | 593 |
| Xiang Liu – | Jan 31, 2025 | Returned to company | −281.02 | $40.92 | $11.50K | 0 |
| Xiang Liu – | Jan 31, 2025 | Option exercise | +281.02 | – | – | 281 |
| Kyle McClements – | Jan 31, 2024 | Option exercise | +625.56 | – | – | 3,361 |
| Kyle McClements – | Jan 31, 2024 | Returned to company | −625.56 | $41.48 | $25.95K | 2,736 |
| Xiang Liu – | Jan 31, 2024 | Option exercise | +188.52 | – | – | 189 |
| Xiang Liu – | Jan 31, 2024 | Returned to company | −188.52 | $41.48 | $7.82K | 0 |
| H. Erin Xie – | Jan 31, 2024 | Option exercise | +14,946.85 | – | – | 14,947 |
| H. Erin Xie – | Jan 31, 2024 | Returned to company | −14,946.85 | $41.48 | $620.00K | 0 |
| Christopher Accettella – | Jan 31, 2024 | Option exercise | +202.81 | – | – | 972 |
| Christopher Accettella – | Jan 31, 2024 | Returned to company | −202.81 | $41.48 | $8.41K | 770 |
| Kyle McClements – | Jan 31, 2023 | Option exercise | +616.13 | – | – | 1,138 |
| Kyle McClements – | Jan 31, 2023 | Returned to company | −616.13 | $43.56 | $26.84K | 522 |
| H. Erin Xie – | Jan 31, 2023 | Returned to company | −13,966.7 | $43.56 | $608.39K | 0 |
| H. Erin Xie – | Jan 31, 2023 | Option exercise | +13,966.7 | – | – | 13,967 |
| Christopher Accettella – | Jan 31, 2023 | Option exercise | +206.29 | – | – | 928 |
| Christopher Accettella – | Jan 31, 2023 | Returned to company | −206.29 | $43.56 | $8.99K | 722 |
| Xiang Liu – | Jan 31, 2023 | Option exercise | +96.11 | – | – | 96 |
| Xiang Liu – | Jan 31, 2023 | Returned to company | −96.11 | $43.56 | $4.19K | 0 |
| Jeffrey Gene Lee – | Jan 31, 2023 | Option exercise | +204.57 | – | – | 205 |
| Jeffrey Gene Lee – | Jan 31, 2023 | Returned to company | −204.57 | $43.56 | $8.91K | 0 |
| Christopher Accettella – | Jan 31, 2022 | Option exercise | +203.01 | – | – | 887 |
| Christopher Accettella – | Jan 31, 2022 | Returned to company | −203.01 | $45.10 | $9.16K | 684 |
| Kyle McClements – | Jan 31, 2022 | Option exercise | +632.03 | – | – | 1,126 |
| Kyle McClements – | Jan 31, 2022 | Returned to company | −632.03 | $45.10 | $28.50K | 494 |
| H. Erin Xie – | Jan 31, 2022 | Returned to company | −15,616.62 | $45.10 | $704.31K | 0 |
| H. Erin Xie – | Jan 31, 2022 | Option exercise | +15,616.62 | – | – | 15,617 |
| Jeffrey Gene Lee – | Jan 31, 2022 | Returned to company | −71.45 | $45.10 | $3.22K | 0 |
| Jeffrey Gene Lee – | Jan 31, 2022 | Option exercise | +71.45 | – | – | 71 |
| Christopher Accettella – | Jan 29, 2021 | Returned to company | −227.87 | $47.88 | $10.91K | 649 |
| Christopher Accettella – | Jan 29, 2021 | Option exercise | +227.87 | – | – | 877 |
| Kyle McClements – | Jan 29, 2021 | Returned to company | −775.71 | $47.88 | $37.14K | 469 |
| Kyle McClements – | Jan 29, 2021 | Option exercise | +775.71 | – | – | 1,245 |
| H. Erin Xie – | Jan 29, 2021 | Returned to company | −13,867.05 | $47.88 | $663.95K | 0 |
| H. Erin Xie – | Jan 29, 2021 | Option exercise | +13,867.05 | – | – | 13,867 |
| H. Erin Xie – | Jan 31, 2020 | Option exercise | +11,391.04 | – | – | 11,391 |
| H. Erin Xie – | Jan 31, 2020 | Returned to company | −11,391.04 | $41.12 | $468.40K | 0 |
| Kyle McClements – | Jan 31, 2020 | Returned to company | −603.75 | $41.12 | $24.83K | 443 |
| Kyle McClements – | Jan 31, 2020 | Option exercise | +603.75 | – | – | 1,047 |
| Christopher Accettella – | Jan 31, 2020 | Returned to company | −158.23 | $41.12 | $6.51K | 610 |
| Christopher Accettella – | Jan 31, 2020 | Option exercise | +158.23 | – | – | 769 |
| Cynthia Egan Director | Jun 28, 2019 | Buy | +3,737 | $38.92 | $145.44K | 3,737 |
| Christopher Accettella – | Jan 31, 2019 | Option exercise | +82.96 | – | – | 660 |
| Christopher Accettella – | Jan 31, 2019 | Returned to company | −82.96 | $39.67 | $3.29K | 577 |
| H. Erin Xie – | Jan 31, 2019 | Returned to company | −4,363.71 | $39.67 | $173.11K | 0 |
| H. Erin Xie – | Jan 31, 2019 | Option exercise | +4,363.71 | – | – | 4,364 |
| Kyle McClements – | Jan 31, 2019 | Returned to company | −325.26 | $39.67 | $12.90K | 417 |
| Kyle McClements – | Jan 31, 2019 | Option exercise | +325.26 | – | – | 742 |
| H. Erin Xie – | Jan 31, 2018 | Option exercise | +1,449.59 | – | – | 1,450 |
| H. Erin Xie – | Jan 31, 2018 | Returned to company | −1,449.59 | $36.21 | $52.49K | 0 |
| Henry Gabbay Director | Dec 9, 2014 | Sale | −650 | $42.19 | $27.42K | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-23.4%
From 0M shares
Short volume, 20 days
50.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BlackRock Health Sciences Trust's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,425 shares on Aug 19, 2026 over the last 90 days.
See a number that looks wrong?